Market Research Logo

»»

Europe Uveitis Market and Competitive Landscape – 2017

Lowest Prices Guaranteed Publisher Published Date SKU
from $3,210 Fore Pharma August, 2017 FPCI15450730
Lowest Prices Guaranteed
Price from $3,210
Publisher Fore Pharma
Published Date August, 2017
SKU FPCI15450730
$3,210
$5,010
 
Research assistance
US: 800.298.5699
Int'l: +1.240.747.3093

Europe Uveitis Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Europe Uveitis Market and Competitive Landscape – 2017, provides comprehensive insights into Uveitis pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Uveitis market size and drug sales. This research also provides insights into Uveitis epidemiology and late stage pipeline.
The report is classified into nine sections – Uveitis overview with definitions, symptoms, etiology, diagnosis, treatment options; Uveitis pipeline insights covering late stage clinical trials pipeline; Uveitis prevalence trends by countries; Uveitis market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes EU5 countries – Germany, France, Italy, Spain, UK, Europe.

Research Scope:

  • Uveitis pipeline: Find out the drugs in clinical trials for Uveitis by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Uveitis epidemiology: Find out the prevalence of Uveitis by countries – Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Uveitis products: Identify key products marketed and prescribed for Uveitis by brand name, by molecule, by company, by branded / generic, by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Uveitis market size: Find out the market size for Uveitis drugs by countries – Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Uveitis drug sales: Find out the sales of Uveitis drugs by countries – Europe, Germany, France, Italy, Spain, UK
  • Uveitis drugs sales forecast: Sales forecast for Uveitis drugs to 2021 by countries – Europe, Germany, France, Italy, Spain, UK, Japan
  • Uveitis market share analysis: Find out the market shares of Uveitis drugs and outlook by countries – Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Uveitis drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Uveitis market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Uveitis market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


1. Uveitis: Disease Overview
1.1. Uveitis Symptoms
1.2. Uveitis Etiology
1.3. Uveitis Diagnosis
1.4. Uveitis Treatment Options
2. Uveitis Pipeline Insights
2.1. Uveitis Phase 3 Clinical Trials
2.2. Uveitis Phase 2 Clinical Trials
2.3. Uveitis Phase 1 Clinical Trials
3. Uveitis Epidemiology Analysis
4. Germany Uveitis Market Insights
4.1. Marketed Products for Uveitis in Germany
4.2. Germany Uveitis Market Size & Forecast
4.3. Germany Uveitis Product Sales Forecast
4.4. Germany Uveitis Market Share Analysis
5. France Uveitis Market Insights
5.1. Marketed Products for Uveitis in France
5.2. France Uveitis Market Size & Forecast
5.3. France Uveitis Product Sales Forecast
5.4. France Uveitis Market Share Analysis
6. Italy Uveitis Market Insights
6.1. Marketed Products for Uveitis in Italy
6.2. Italy Uveitis Market Size & Forecast
6.3. Italy Uveitis Product Sales Forecast
6.4. Italy Uveitis Market Share Analysis
7. Spain Uveitis Market Insights
7.1. Marketed Products for Uveitis in Spain
7.2. Spain Uveitis Market Size & Forecast
7.3. Spain Uveitis Product Sales Forecast
7.4. Spain Uveitis Market Share Analysis
8. UK Uveitis Market Insights
8.1. Marketed Products for Uveitis in UK
8.2. UK Uveitis Market Size & Forecast
8.3. UK Uveitis Product Sales Forecast
8.4. UK Uveitis Market Share Analysis
9. Europe Uveitis Market Insights
9.1. Europe Uveitis Market Size & Forecast
9.2. Europe Uveitis Product Sales Forecast
9.3. Europe Uveitis Market Share Analysis
10. Research Methodology
LIST OF TABLES
Table 1: Uveitis Phase 3 Clinical Trials, Global, 2017
Table 2: Uveitis Phase 2 Clinical Trials, Global, 2017
Table 3: Uveitis Phase 1 Clinical Trials, Global, 2017
Table 4: Uveitis Prevalence by EU5 Countries, 2012 - 2021
Table 5: Marketed Products for Uveitis in Germany, 2017
Table 6: Germany Uveitis Market Size & Forecast ($mn), 2012 - 2021
Table 7: Germany Uveitis Product Sales ($mn), 2012 - 2021
Table 8: Germany Uveitis Market Trends, 2012 - 2021
Table 9: Marketed Products for Uveitis in France, 2017
Table 10: France Uveitis Market Size & Forecast ($mn), 2012 - 2021
Table 11: France Uveitis Product Sales ($mn), 2012 - 2021
Table 12: France Uveitis Market Trends, 2012 - 2021
Table 13: Marketed Products for Uveitis in Italy, 2017
Table 14: Italy Uveitis Market Size & Forecast ($mn), 2012 - 2021
Table 15: Italy Uveitis Product Sales ($mn), 2012 - 2021
Table 16: Italy Uveitis Market Trends, 2012 - 2021
Table 17: Marketed Products for Uveitis in Spain, 2017
Table 18: Spain Uveitis Market Size & Forecast ($mn), 2012 - 2021
Table 19: Spain Uveitis Product Sales ($mn), 2012 - 2021
Table 20: Spain Uveitis Market Trends, 2012 - 2021
Table 21: Marketed Products for Uveitis in UK, 2017
Table 22: UK Uveitis Market Size & Forecast ($mn), 2012 - 2021
Table 23: UK Uveitis Product Sales ($mn), 2012 - 2021
Table 24: UK Uveitis Market Trends, 2012 - 2021
Table 25: Europe Uveitis Market Size & Forecast ($mn), 2012 - 2021
Table 26: Europe Uveitis Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Uveitis Pipeline by Phase (%), Global, 2017
Figure 2: Uveitis Prevalence by EU5 Countries, 2012 - 2021
Figure 3: Germany Uveitis Market Size ($mn), 2012 - 2021
Figure 4: Germany Uveitis Product Sales ($mn), 2012 - 2021
Figure 5: Germany Uveitis Market Share by Products (%), 2016
Figure 6: Germany Uveitis Market - Future Market Share (%), 2021
Figure 7: France Uveitis Market Size ($mn), 2012 - 2021
Figure 8: France Uveitis Product Sales ($mn), 2012 - 2021
Figure 9: France Uveitis Market Share by Products (%), 2016
Figure 10: France Uveitis Market - Future Market Share (%), 2021
Figure 11: Italy Uveitis Market Size ($mn), 2012 - 2021
Figure 12: Italy Uveitis Product Sales ($mn), 2012 - 2021
Figure 13: Italy Uveitis Market Share by Products (%), 2016
Figure 14: Italy Uveitis Market - Future Market Share (%), 2021
Figure 15: Spain Uveitis Market Size ($mn), 2012 - 2021
Figure 16: Spain Uveitis Product Sales ($mn), 2012 - 2021
Figure 17: Spain Uveitis Market Share by Products (%), 2016
Figure 18: Spain Uveitis Market - Future Market Share (%), 2021
Figure 19: UK Uveitis Market Size ($mn), 2012 - 2021
Figure 20: UK Uveitis Product Sales ($mn), 2012 - 2021
Figure 21: UK Uveitis Market Share by Products (%), 2016
Figure 22: UK Uveitis Market - Future Market Share (%), 2021
Figure 23: Europe Uveitis Market Size ($mn), 2012 - 2021
Figure 24: Europe Uveitis Product Sales ($mn), 2012 - 2021
Figure 25: Europe Uveitis Market Share by Products (%), 2016
Figure 26: Europe Uveitis Market - Future Market Share (%), 2021

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

Other tasks